Literature DB >> 156814

[Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

D Huhn, W Wilmanns.   

Abstract

Optimal treatment in Hodgkin's disease requires the knowledge of the stage the disease has reached. Laboratory tests, x-ray and scintigraphy, usually, are not sufficient, but biopsies of bone marrow and liver are necessary, in special cases supplemented by laparoscopy or explorative laparotomy with splenectomy. As treatment of choice, irradiation is favored for disease restricted to lymph nodes, and cytostatics for disease complicated by severe symptoms or by organ involvement. Diagnosis and therapy should be adapted to the individual patient. New therapeutic approaches must be compared with the sometimes excellent results obtained by several institutions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156814     DOI: 10.1007/bf01480475

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  88 in total

1.  Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.

Authors:  G R Siber; S A Weitzman; A C Aisenberg; H J Weinstein; G Schiffman
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

2.  Long term remissions with combined modality therapy for advanced Hodgkin's disease.

Authors:  L R Prosnitz; L R Farber; J J Fischer; J R Bertino; D B Fischer
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  [Hodgkin's disease: effect of spenectomy on the immune status (author's transl)].

Authors:  V Diehl; M Schaadt; R J Kalden; C Hagedorn; N Schmidt; J Deinhardt
Journal:  Klin Wochenschr       Date:  1978-08-15

4.  Proceedings: An evaluation of the effects of splenectomy in Hodgkin's disease in patients undergoing extended field or total lymph node irradiation.

Authors:  R L Royster; J A Wassum; E R King
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-03

5.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

6.  Hodgkin's disease stage I and II. A comparison between two different treatment policies.

Authors:  T J Stoffel; J D Cox
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

7.  The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine.

Authors:  R D Warren; R A Bender; L Norton; R C Young
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

8.  Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.

Authors:  R K Desser; H M Golomb; J E Ultmann; D J Ferguson; E M Moran; M L Griem; J Vardiman; B Miller; N Oetzel; D Sweet; E P Lester; J J Kinzie; R Blough
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

9.  Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.

Authors:  D C Ihde; V T DeVita; G P Canellos; R C Young
Journal:  Blood       Date:  1976-02       Impact factor: 22.113

10.  Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.

Authors:  R C Young; G P Canellos; B A Chabner; S M Hubbard; V T DeVita
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

View more
  1 in total

1.  [Treatment results of Hodgkin's disease, stages I and II (author's transl)].

Authors:  W Gassmann; H Pralle; H Löffler; M Gluth-Stender
Journal:  Klin Wochenschr       Date:  1981-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.